Interactions on record — worth a quick check against your medications. Based on 2 of 4 ingredients. Check your meds →
Dietary supplement

Monster Maize Blue Raspberry Ingredients & Drug Interactions

by CytoSport

Powder Category: Other Combinations
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Monster Maize Blue Raspberry is a dietary supplement by CytoSport with 4 active ingredients. Its ingredients are commonly taken for replacing fluids and electrolytes, preventing dehydration during exercise or illness, treating low blood sodium (under medical care).Based on those ingredients, 220 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Sodium, Potassium. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Monster Maize Blue Raspberry by CytoSport

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 3 of its 3 active ingredients.
  • No proprietary blends here — you can verify the dose of every single component.

Monster Maize Blue Raspberry has 3 active ingredients: sodium, potassium, and Carbogen®. Sodium and potassium are electrolytes your body needs for muscle, nerve, and heart function — they're especially important for athletes during intense activity and recovery.

The product also contains a Monster Maze unique complex carbohydrate blend as an inactive ingredient to deliver these electrolytes and provide fuel.

Does it work?

Strong evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed

This product doesn't appear to be marketed for a specific use, so we graded its ingredients' overall clinical evidence instead.

Strong

Strong clinical evidence supports its ingredients for:

Why this rating?
  • We looked at the product name, claims, and label statements and couldn't find a stated purpose to grade.
  • Since the label doesn't commit to one use, we graded the ingredients' overall clinical evidence instead.
  • On file: Cystic fibrosis — rated "Likely Effective" (Sodium) (Natural Medicines).
  • On file: Amphotericin B nephrotoxicity — rated "Possibly Effective" (Sodium) (Natural Medicines).

We hold effectiveness ratings only for sodium, and they're limited: it's listed as likely effective for cystic fibrosis and possibly effective for amphotericin B nephrotoxicity (a type of kidney damage from a specific antifungal drug). No effectiveness data is on file for potassium or Carbogen® in this context, and these ingredients are being used here as electrolyte and carbohydrate components of a sports drink rather than as standalone treatments.

The evidence we have doesn't address whether this product works as intended for athletic performance or recovery.

The evidence, ingredient by ingredient Sodium Potassium

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Sodium is well tolerated in normal dietary amounts up to the recommended daily limit of 2.3 grams, but too much sodium is linked to high blood pressure and strain on your heart and kidneys. Potassium from food is safe, but supplements can raise your blood levels dangerously — especially risky if you have kidney disease.

The most common side effects from potassium supplements are stomach upset, nausea, diarrhea, and belly pain; serious but rare effects include irregular heartbeat and low blood pressure. For pregnancy and lactation, sodium is listed as likely safe, though one rating flags it as possibly unsafe — talk with your doctor or pharmacist about whether this product is right for you if you're pregnant or breastfeeding.

We hold no safety data for Carbogen®.

Side effects, ingredient by ingredient Sodium Potassium

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 2 of the 2 matched ingredients can interact with medications — Potassium, Sodium.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: lithium.
  • For scale: 220 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Check before using this product if you take blood pressure medications (ACE inhibitors, ARBs, antihypertensive drugs), potassium-sparing diuretics, corticosteroids, lithium, didanosine, sodium phosphates, or tolvaptan. All of these have Moderate-severity interactions with either the sodium or potassium in this drink, and the risks include reduced medication effectiveness, dangerously high sodium or potassium levels, and serious heart problems.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with strong clinical evidence behind its ingredients' uses. Moderate medication interactions have been identified, and safety information is well characterized.

This is a sports drink meant to replace electrolytes during or after intense exercise. If you take blood pressure medications — ACE inhibitors, ARBs, potassium-sparing diuretics — or if you take lithium or corticosteroids, you need to check with your own doctor or pharmacist before using it, because the sodium and potassium can interfere with how those drugs work or create unsafe electrolyte levels.

Talk it over with your healthcare provider, especially if you have kidney disease or heart problems.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 3 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Oct 1, 2012.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Monster Maize Blue Raspberry, straight from the product label.

Brand CytoSport
Barcode (UPC) 660726798300
Net contents 2.98 lbs; 1350 Gram(s)
Market status On market
Date entered into DSLD Oct 1, 2012
DSLD ID 12817
Product type Other Combinations
Supplement form Powder
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Monster Maize Blue Raspberry by CytoSport, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
45 Gram(s)
Maximum serving Sizes:
45 Gram(s)
Servings per container
30
UPC/BARCODE
660726798300
IngredientAmount% DV
Calories160 {Calories}--
Total Carbohydrates40 g13%
Sugar1 g--
Sodium170 mg7%
Potassium290 mg8%
Carbogen(R)100 mg--

Other ingredients: MONSTER MAZE UNIQUE COMPLEX CARBOHYDRATE BLEND

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

MONSTER MAIZE(TM) is designed to be the most powerful glycogen-replenishing, muscle-hydrating carbohydrate drink available. Unlike other products with waxy maize starch, Monster Maize mixes easily in a shaker and has phenomenal taste. Monster Maize is the ultimate carbohydrate system that rapidly provides massive amounts of glucose energy to fuel monster results. 40G COMPLEX CARBS Monster Maize complex carbohydrates deliver a unique blend of amylopectin (waxy maize starch) and long chain glucose polymers (maltodextrin). These carbohydrates are rapidly broken down into muscle fueling glucose. This valuable fuel helps spare muscle glycogen allowing for its use in post-workout recovery. WHY 40 GRAMS? When Monster Maize is mixed as directed (1 scoop/16 fl-oz) the 40 grams of carbohydrates are in the optimal concentration, 6%-8% solution. This concentration of carbohydrates in water is widely recognized to have the best osmolality allowing for rapid uptake and delivery to working muscles. ENHANCE NUTRIENT DELIVERY Monster Maize carbohydrates can help accelerate the delivery of other performance supplements. The high molecular weights of these specialty carbohydrates help them reach the intestines rapidly. This rapid transit allows for added supplements like creatine, BCAA’s and NO (Nitric Oxide) factors reach the intestines sooner.

Rapid digestion increases blood glucose levels. Increased blood glucose provides muscles with their preferred fuel source which helps protect and preserve valuable muscle glycogen. THIS STUFF REALLY IS MONSTER. DO NOT USE WITH CAUTION. BE A MONSTER.

MONSTERIZE YOUR WORKOUTS! MONSTER PRODUCTS ARE FOR THE DEDICATED ATHLETE DETERMINED TO BECOME A FREAK OF NATURE! IF YOU WANT TO REACH THE NEXT LEVEL IN TRAINING AND SIZE, THEN YOU NEED MONSTER NUTRITION AND MONSTER DETERMINATION. USE THIS RECOMMENDED MONSTERIZE STACK TO MAXIMIZE YOUR GAINS. DO NOT USE WITH CAUTION. BE A MONSTER.

TO BUILD MONSTER MUSCLE YOU NEED MONSTER MAIZE!

RAPID NUTRIENT DELIVERY HYDRATE MUSCLE TISSUES

NATURE’S ULTIMATE COMPLEX CARB FORMULA

SUSTAINED INSULIN RESPONSE

Naturally and Artificially Flavored

1-888-CYTOMAX

Suggested/Recommended/Usage/Directions

1.5-2 HOURS PRE-WORKOUT MONSTER MILK(TM) Drink MONSTER MILK 1.5-2 hours pre-workout for sustained energy to carry you through intense workouts. 15 MINUTES PRE-WORKOUT MONSTER PUMP(TM) Drink MONSTER PUMP 15 minutes prior to your workout for sustained energy, muscle-expanding pumps, increased mental focus. DURING WORKOUT MONSTER MAIZE(TM) Drink MONSTER MAIZE during your workout to maintain high muscle glucose concentrations for muscle hydration, sustained energy and power. IMMEDIATELY POST-WORKOUT MONSTER AMINO(TM) Drink MONSTER AMINO immediately post-workout for amino acid rich blood flow into hungry muscles. 30 MIN-1.5 HOURS POST-WORKOUT MONSTER MILK(TM) Drink MONSTER MILK 30 minutes-1.5 hours post-workout to create a positive nitrogen balance. MONSTER MILK provides your body with 50g protein, creatine, peptides and free-form amino acids to maximize workout gains and speed recovery.

DIRECTIONS MIX 1 SCOOP (45g) MONSTER MAIZE INTO 16 FL-OZ WATER.

Formula

ULTRA-DIGESTIBLE Monster Maize contains 100mg of Carbogen(R) to accelerate digestion and breakdown of Monster Maize Complex Carbohydrates.

40g COMPLEX CARBS Per Serving

Brand IP Statement(s)

NEW! FROM THE MAKERS OF MUSCLE MILK(R)

(C)2009 CYTOSPORT, INC.

Carbogen is a registered trademark of Triarco Industries

INCREASE BLOOD GLUCOSE CARBOGEN(R)

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Precautions

This product is manufactured in a facility that processes milk, soy, wheat and eggs.

Seals/Symbols

MADE IN USA

CARBOGEN(TM)

General

79830-REV1.05/09

FDA Statement of Identity

DIETARY SUPPLEMENT

See for yourself

Monster Maize Blue Raspberry by CytoSport label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Monster Maize Blue Raspberry by CytoSport

These are the 4 active ingredients this product is made of. Select any to open its full monograph.

Serving size45 Gram(s) Dosage formPowder Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Sugar

1 g per serving

Sodium

Interacts with
205 drugs
170 mg per serving

Sodium is an essential mineral and electrolyte your body needs to balance fluids, support nerves, and help muscles work. Most people in modern diets g...

Sodium monograph & interactions

Potassium

Interacts with
62 drugs
290 mg per serving

Potassium is an essential mineral your body needs for nerve signals, muscle function, and a steady heartbeat, and most people get enough from a balanc...

Potassium monograph & interactions

Carbogen(R)

100 mg per serving

Other (inactive) ingredients: MONSTER MAZE UNIQUE COMPLEX CARBOHYDRATE BLEND. These complete the product’s ingredient list but are not active constituents.

Interaction report

Monster Maize Blue Raspberry by CytoSport Drug Interactions

Want to check YOUR meds against Monster Maize Blue Raspberry?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
220Drugs
220 Moderate

Ingredients driving the most interactions

Sodium 205

Each ingredient & the kinds of drugs it affects

For each ingredient in Monster Maize Blue Raspberry with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Sodium7 drug types · 205 drugs

Antihypertensive Drugs

Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
High intake of dietary sodium can increase systolic and diastolic blood pressure. Also, high intake of sodium may necessitate increased use of antihypertensive medications to achieve blood pressure control in some patients, such as those with chronic kidney disease.

Likelihood Probable Evidence A
Corticosteroids

Concomitant use of mineralocorticoids and some glucocorticoids with sodium supplements might increase the risk of hypernatremia.
Mineralocorticoids and some glucocorticoids (corticosteroids) cause sodium retention. This effect is dose-related and depends on mineralocorticoid potency. It is most common with hydrocortisone, cortisone, and fludrocortisone, followed by prednisone and prednisolone.

Likelihood Possible Evidence D
Didanosine (Videx)

Concomitant use of didanosine with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia.
Didanosine formulations contain a significant amount of sodium.

Likelihood Probable Evidence C
Lithium

Altering dietary intake of sodium might alter the levels and clinical effects of lithium.
High sodium intake can reduce plasma concentrations of lithium by increasing lithium excretion. Reducing sodium intake can significantly increase plasma concentrations of lithium and cause lithium toxicity in patients being treated with lithium carbonate. Stabilizing sodium intake is shown to reduce the percentage of patients with lithium level fluctuations above 0.8 mEq/L. Patients taking lithium should avoid significant alterations in their dietary intake of sodium.

Likelihood Probable Evidence B
Sodium Phosphates

Theoretically, concomitant use of sodium phosphate with sodium supplements might increase the risk of hypernatremia.
Use of high doses (> 45 mL in 24 hours) of sodium phosphate, such as those used for bowel cleansing before surgery, can lead to serious electrolyte disturbances, including hypernatremia. The risk of hypernatremia is highest in the elderly and people with other risk factors for electrolyte disturbances.

Likelihood Possible Evidence D
Sodium-Containing Drugs

Concomitant use of sodium-containing drugs with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia and long-term sodium-related complications.
The Chronic Disease Risk Reduction (CDRR) intake level of 2.3 grams of sodium daily indicates the intake at which it is believed that chronic disease risk increases for the apparently healthy population. Some medications contain high quantities of sodium. When used in conjunction with sodium supplements or high-sodium diets, the CDRR may be exceeded. Additionally, concomitant use may increase the risk for hypernatremia; this risk is highest in the elderly and people with other risk factors for electrolyte disturbances.

Likelihood Possible Evidence D
Tolvaptan (Samsca)

Theoretically, concomitant use of tolvaptan with sodium might increase the risk of hypernatremia.
Tolvaptan is a vasopressin receptor 2 antagonist that is used to increase sodium levels in patients with hyponatremia. Patients taking tolvaptan should use caution with the use of sodium salts such as sodium chloride.

Likelihood Probable Evidence C

Potassium3 drug types · 62 drugs

Ace Inhibitors (Aceis)

Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
ACEIs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.

Likelihood Likely Evidence C
Angiotensin Receptor Blockers (Arbs)

Using ARBs with high doses of potassium increases the risk of hyperkalemia.
ARBs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.

Likelihood Likely Evidence C
Potassium-Sparing Diuretics

Concomitant use increases the risk of hyperkalemia.
Using potassium-sparing diuretics with potassium supplements increases the risk of hyperkalemia.

Likelihood Likely Evidence C
The maker

Brand information

Manufacturer and brand details for Monster Maize Blue Raspberry, from the product label.

CytoSport

See all CytoSport products
Phone Number
1-888-298-6629
Pharmacist Counseling Corner

Monster Maize Blue Raspberry by CytoSport: Common Questions

Does Monster Maize Blue Raspberry by CytoSport interact with any medications?
Yes. Based on its ingredients, Monster Maize Blue Raspberry has a known interaction with 220 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Monster Maize Blue Raspberry contains 4 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is this okay to use if I take blood pressure medication?
Not without checking first. The sodium and potassium in this product can make your blood pressure drugs less effective or raise your electrolyte levels to unsafe ranges. Talk to your doctor or pharmacist before starting it — they know your exact medications and can advise whether it's safe for you.
Can I use this if I have kidney disease?
That's a conversation for your doctor or pharmacist. Potassium supplements are risky for people with kidney problems because your kidneys may not clear excess potassium safely. The sodium content is also a concern if you have heart or kidney disease.
What does Carbogen® do in this product?
We hold no data for Carbogen®, so we can't tell you its role or effects. Check the manufacturer's label or contact them directly for details on that ingredient.
Can I use this during pregnancy?
The sodium in this product is listed as likely safe during pregnancy, though one rating flags it as possibly unsafe — the data is mixed. Potassium from food is safe, but supplements need medical guidance. Talk with your doctor or pharmacist about whether this product is right for your pregnancy specifically.
What are the side effects from potassium?
Common ones are stomach pain, belching, diarrhea, gas, nausea, and vomiting. Serious but rare effects — usually from too much potassium — are irregular heartbeat, heart block, low blood pressure, and confusion.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Monster Maize Blue Raspberry is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Monster Maize Blue Raspberry label
Sources

Sources & How We Checked

Monster Maize Blue Raspberry's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 50 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Sodium 38 references
  1. Garabedian-Ruffalo SM, Ruffalo RL. Drug and nutrient interactions. Am Fam Physician 1986;33:165-74.
  2. Food and Drug Administration Science Background: Safety of Sodium Phosphates Oral Solution. September 17, 2001. Available at: http://www.fda.gov/cder/drug/safety/sodiumphospate.htm
  3. Coton T, Mallaret C, Coilliot C, Carre D, Guisset M. Severe acute ulcerated gastritis induced by salt. Presse Med 2009;38(3):499-500. PubMed
  4. Frings-Meuthen P, Buehlmeier J, Baecker N, et al. High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol 2011;111(2):537-542. PubMed
  5. Frings-Meuthen P, Baecker N, Heer M. Low-grade metabolic acidosis may be the cause of sodium chloride-induced exaggerated bone resorption. J Bone Miner Res 2008;23(4):517-524. PubMed
  6. Alam S, Johnson AG. A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure. J Hum Hypertens 1999;13(6):367-74.
  7. Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 2005;18(10):1300-5. PubMed
  8. Bennett WM. Drug interactions and consequences of sodium restriction. Am J Clin Nutr 1997;65(2 Suppl):678S-681S. PubMed
  9. Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97(4):383-9. PubMed
  10. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academy Press, 2005. Available at: http://www.nap.edu/openbook.php?record_id=10925. DOI
  11. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31(4):489-98. PubMed
  12. Goldsmith SR. Hyponatremia in heart failure: time for a trial. J Card Fail 2013;19(6):398-400. PubMed
  13. Willocks L, Brettle R, Keen J, Valentine C, Pinching AJ. Formulations of didanosine (ddI) and salt overload. Lancet 1992;339(8786):190.
  14. Chen L, Zhang Z, Chen W, Whelton PK, Appel LJ. Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly. Am J Public Health. 2016;106(7):1270-5. PubMed
  15. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129(9):981-9. PubMed
  16. Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol. 2016;68(15):1609-1617. PubMed
  17. Mente A, O'Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388(10043):465-75. PubMed
  18. Moosavian SP, Haghighatdoost F, Surkan PJ, Azadbakht L. Salt and obesity: a systematic review and meta-analysis of observational studies. Int J Food Sci Nutr. 2017;68(3):265-277. PubMed
  19. O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612-23. DOI
  20. Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18(4):695-704. PubMed
  21. Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad
  22. Mahtani KR, Heneghan C, Onakpoya I, et al. Reduced Salt Intake for Heart Failure: A Systematic Review. JAMA Intern Med. 2018 Dec 1;178(12):1693-1700. PubMed
  23. Yancy CW. Sodium Restriction in Heart Failure: Too Much Uncertainty-Do the Trials. JAMA Intern Med. 2018 Dec 1;178(12):1700-1701. PubMed
  24. He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47(6):1784-1795. PubMed
  25. Murthy K, Ondrey GJ, Malkani N, et al. THE EFFECTS OF HYPONATREMIA ON BONE DENSITY AND FRACTURES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2019;25(4):366-378. PubMed
  26. Messerli FH, Hofstetter L, Syrogiannouli L, et al. Sodium intake, life expectancy, and all-cause mortality. Eur Heart J 2021;42(21):2103-2112. PubMed
  27. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2020;12(12):CD004022. PubMed
  28. Giatti S, Santos RB, Aielo AN, et al. Association of sodium with obstructive sleep apnea. The ELSA-Brasil study. Ann Am Thorac Soc 2021;18(3):502-510. PubMed
  29. Nan X, Lu H, Wu J, et al. The interactive association between sodium intake, alcohol consumption and hypertension among elderly in northern China: a cross-sectional study. BMC Geriatr 2021;21(1):135. PubMed
  30. Kyozuka H, Fukusda T, Murata T, et al. Impact of preconception sodium intake on hypertensive disorders of pregnancy: The Japan Environment and Children's study. Pregnancy Hypertens 2021;23:66-72. PubMed
  31. Zhao L, Ogden CL, Yang Q, et al. Association of usual sodium intake with obesity among US children and adolescents, NHANES 2009-2016. Obesity (Silver Spring) 2021;29(3):587-594. PubMed
  32. Ma Y, He FJ, Sun Q, et al. 24-Hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med 2022;386(3):252-263. PubMed
  33. Liu J, Yang X, Zhang P, et al. Association of urinary sodium excretion and left ventricular hypertrophy in people with type 2 diabetes mellitus: A cross-sectional study. Front Endocrinol (Lausanne) 2021;12:728493. PubMed
  34. Filippini T, Malavolti M, Whelton PK, Vinceti M. Sodium intake and risk of hypertension: A systematic review and dose-response meta-analysis of observational cohort studies. Curr Hypertens Rep 2022;24(5):133-144. PubMed
  35. Wang DD, Li Y, Nguyen XT, et al. Dietary sodium and potassium intake and risk of non-fatal cardiovascular diseases: The million veteran program. Nutrients 2022;14(5):1121. PubMed
  36. Kwak JH, Park CH, Eun CS, et al. The associations of dietary intake of high sodium and low zinc with gastric cancer mortality: A prospective cohort study in Korea. Nutr Cancer 2022;74(10):3501-3508. PubMed
  37. George S, Maiti R, Mishra BR, Jena M, Mohapatra D. Effect of regulated add-on sodium chloride intake on stabilization of serum lithium concentration in bipolar disorder: A randomized controlled trial. Bipolar Disord 2023;25(1):66-75. PubMed
  38. Zhou TL, Schütten MTJ, Kroon AA, et al. Urinary Sodium Excretion and Salt Intake Are Not Associated With Blood Pressure Variability in a White General Population. J Am Heart Assoc 2023;12(1):e026578. PubMed

See these in context on the Sodium monograph →

Potassium 12 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Gennaro A. Remington: The Science and Practice of Pharmacy. 19th ed. Lippincott: Williams & Wilkins, 1996.
  3. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32. PubMed
  4. Phillips, C. O., Kashani, A., Ko, D. K., Francis, G., and Krumholz, H. M. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from ra DOI
  5. Altieri, P. I., Herrero, C., Suero, R., and Ortiz, A. Bleeding duodenal ulcer in a patient taking slow-releasing potassium tablets. Bol.Asoc.Med P.R. 1977;69(8):276.
  6. Raf, L. E. Enteric-coated potassium chloride tablets and ulcer of the small intestine. Acta Chir Scand Suppl 1967;(374):1-87.
  7. Potassium chloride oral solution [package insert]. Allentown, PA: Lehigh Valley Technologies, Inc.; 2014.
  8. Potassium chloride injection [package insert]. Lake Forest, IL: Hospira Inc.; 2009.
  9. Patel RB, Tannenbaum S, Viana-Tejedor A, et al. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 2017 Feb;6(1):1 PubMed
  10. Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system. Am J Clin Nutr 2016 Oct;104(4 PubMed
  11. Keskin M, Kaya A, Tatlisu MA, et al. The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J cardiol. 2016 Oct 15;221:505-10.
  12. Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad

See these in context on the Potassium monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring